Roman Butler Fullerton & Co. Boosts Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Roman Butler Fullerton & Co. boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 18.4% during the second quarter, HoldingsChannel reports. The fund owned 1,156 shares of the healthcare conglomerate’s stock after buying an additional 180 shares during the period. Roman Butler Fullerton & Co.’s holdings in UnitedHealth Group were worth $579,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Wedmont Private Capital increased its position in shares of UnitedHealth Group by 78.3% during the second quarter. Wedmont Private Capital now owns 10,941 shares of the healthcare conglomerate’s stock worth $5,597,000 after acquiring an additional 4,804 shares during the period. Voisard Asset Management Group Inc. boosted its stake in shares of UnitedHealth Group by 30.3% during the second quarter. Voisard Asset Management Group Inc. now owns 731 shares of the healthcare conglomerate’s stock worth $372,000 after buying an additional 170 shares during the period. Bangor Savings Bank boosted its stake in shares of UnitedHealth Group by 4.5% during the second quarter. Bangor Savings Bank now owns 783 shares of the healthcare conglomerate’s stock worth $399,000 after buying an additional 34 shares during the period. First Community Trust NA lifted its position in UnitedHealth Group by 21.3% in the second quarter. First Community Trust NA now owns 388 shares of the healthcare conglomerate’s stock valued at $198,000 after purchasing an additional 68 shares during the period. Finally, Buckingham Capital Management Inc. lifted its position in shares of UnitedHealth Group by 0.7% during the 2nd quarter. Buckingham Capital Management Inc. now owns 25,451 shares of the healthcare conglomerate’s stock valued at $12,961,000 after acquiring an additional 168 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Up 1.6 %

UnitedHealth Group stock traded up $8.95 during midday trading on Tuesday, reaching $574.24. The stock had a trading volume of 2,361,879 shares, compared to its average volume of 4,259,504. The firm’s fifty day simple moving average is $523.19 and its two-hundred day simple moving average is $505.39. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $591.54. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.85. The firm has a market cap of $528.52 billion, a price-to-earnings ratio of 34.97, a PEG ratio of 1.56 and a beta of 0.59.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. During the same quarter last year, the business posted $6.14 EPS. The company’s revenue was up 6.4% on a year-over-year basis. Equities analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be given a $2.10 dividend. The ex-dividend date is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.46%. UnitedHealth Group’s payout ratio is 51.34%.

Analysts Set New Price Targets

Several brokerages recently issued reports on UNH. Cantor Fitzgerald restated an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, July 23rd. Argus upped their price objective on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. HSBC upped their price target on shares of UnitedHealth Group from $580.00 to $610.00 in a research report on Thursday, July 18th. Baird R W raised shares of UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. Finally, Truist Financial upped their price objective on shares of UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. One investment analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $614.17.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.